Home
Account
Research Tools
Educate
Contribute
News
Sectors
Premium
About Us
Subscribe
Login
Manage Account
Quote and Research
Stock Charts
Earnings Calendar
Technical Scans
Chart School
Tutorials
Learning Center
Glossary
Submit Article
Join Blog Network
Rate Broker
Rate Software
Earnings
Dividend
Management Changes
M&A
Analyst
FDA
IPO
About Us
Contact Us
Advertise With Us
Editorial Staff
Terms and Conditions
Privacy Policy
iStock Rating
B
Details...
Enter Symbol
Peregrine Pharmaceuticals Inc. (NASDAQ: PPHM)
Sector: Medical
Current Price :
$5.39
52 Week Low
$0.40
52 Week High
$5.39
Company
Overview
Research Notes
Company Profile
Competitors
Community
Stock Sentiment
Whisper Estimates
Enter Estimates
Message Board
Analysis
Blog Articles
Press Releases
Charts
Technical Charts
Analyst
Analyst Ratings
Analyst Estimates
Sales Estimates
Ratios
Financial Ratios
Technicals
Shares Outstanding:
137M
Market Cap:
$0.21B
Avg Volume:
1724116
P/E Ratio:
-0.010
PEG Ratio:
-0.010
Split:
On 10/19/2009 pphm split by factor of 0.200
1m
3m
6m
1y
2y
Opinion and Analysis
Tough, Volatile Session Ends Lower
Nov 27, 2012 10:19 PM |
AAPL
,
ACAD
,
AMRN
,
AMZN
,
APKT
,
APOG
Big Negative Afternoon Reversal
Sep 25, 2012 11:25 PM |
AAPL
,
ADAM
,
AMZN
,
ANF
,
ASML
,
BIG
Narrow Close But Positive Session
Sep 19, 2012 09:20 PM |
ACHN
,
AKRX
,
CBRL
,
CQB
,
CYCC
,
GOOG
More Articles on PPHM..
Press Releases
Before the Crowd, How We Found JPM, PPHM, BSX and GLW
May 21, 2013 11:00 AM |
BSX
,
GLW
,
JPM
,
PPHM
Free Research Reports on CPB, JASO, PPHM and YHOO Issued by the Bedford Report
May 21, 2013 08:15 AM |
CPB
,
JASO
,
PPHM
,
YHOO
Peregrine Pharmaceuticals Reaches Agreement With FDA on a Phase III Trial Design for Bavituximab in Second-Line Non-Small Cell Lung Cancer
May 20, 2013 08:47 AM |
PPHM
More Press Releases on PPHM..
SEC Filings
Form 4 PEREGRINE PHARMACEUTICAL For: Dec 27 Filed by: Shan Joseph (10K)
Dec 28, 2012 04:32 PM
Form 4 PEREGRINE PHARMACEUTICAL For: Dec 27 Filed by: Ziebell Mark R (10K)
Dec 28, 2012 04:32 PM
Form 4 PEREGRINE PHARMACEUTICAL For: Dec 27 Filed by: SWARTZ ERIC S (10K)
Dec 28, 2012 04:31 PM
Sentiment Survey
Avg. Short Term
Avg. Long Term
Avg. Grade
More Details
Share Performance
Period
PPHM
Compare to S&P
YTD
15.91 %
6.29 %
4 Weeks
11.68 %
11.80 %
12 Weeks
-26.09 %
-28.57 %
More...
Financial Ratios
Earnings Performance
EPS Growth in Last Quarter:
33.33 %
EPS Growth in Last Year:
69.23 %
Sales Growth in Last Quarter:
14.66 %
Sales Growth in Last Quarter:
114.54 %
More...
Fundamental data is provided by
Zacks Investment Research
, and Commentary, news and Press Releases provided by YellowBrix and
Quotemedia
. Advertisement partners
Investing Channel
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.
{1}
##LOC[OK]##
{1}
##LOC[OK]##
##LOC[Cancel]##
{1}
##LOC[OK]##
##LOC[Cancel]##